Patent · US Active

Glucosamine derivatives for the prevention or treatment of joint disorders

US11718636B2 · kind B2 · utility

0Cited by

3References

19Claims

0Family size

Assignee

RISEN (SUZHOU) PHARMA TECH CO., LTD. · CN

Inventors

Xianqi Kong · Dollard-Des-Ormeaux, CA
Jiasheng LU · Shanghai, CN
Jiamin GU · Suzhou, CN
Xiang JI · Suzhou, CN
Daiqiang HU · Suzhou, CN
Xiuchun ZHANG · Suzhou, CN
Xinyong LV · Suzhou, CN
Jinchao AI · Suzhou, CN
Dongdong Wu · Shanghai, CN
Lin Wang · University City, US
Dongqing Zhu · Suzhou, CN
Xiaolin HE · 安丰镇, CN

Key dates

Filing date	Dec 17, 2018
Grant date	Aug 8, 2023
Priority date	—
Expiry date	Sep 11, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/05
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There are provided compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for the prevention or treatment in a mammal of joint and bone disorders such as arthritis and osteoporosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.